Pediatrix Medical Group Inc (MD)

Pediatrix Medical Group Inc. is a common stock listing on the NYSE for Pediatrix Medical Group, Inc., a U.S. healthcare company focused on newborn, maternal-fetal, and other pediatric subspecialty care. Through its subsidiaries and affiliated clinicians, the company provides clinical services for premature infants and newborns with complications, largely in hospital NICU settings, as well as inpatient and office-based care for expectant mothers and unborn babies. Its broader pediatric services include intensive care, hospitalist, and surgical support, along with related hospital-based services such as emergency room, labor and delivery, nursery, pediatric department support, and newborn hearing screening. Formerly known as MEDNAX, Inc., the company adopted its current name in July 2022. Pediatrix Medical Group was founded in 1979 and is based in Sunrise, Florida.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-MD
$32.08
23.7% Upside
Undervalued
$26.33
1.6% Upside
Fair
Great
0.0%
October 29, 2026
11.6x
2.3x
1.0x
2.057 B
2.238 B
23.2%
98.2%
4.4
130.8%
Valuation • Fair Value

Pediatrix Medical Group Inc (NYSE-MD) Fair Value by Valuation Model

Review the available estimates for Pediatrix Medical Group Inc (NYSE-MD), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$32.08

Estimated upside of 23.7% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$38.33

Discounted cash flow valuation reference.

Ben Graham Formula Value

$24.45

Classic Ben Graham valuation formula reference.

EPV Fair Value

$24.69

Earnings power value estimate.

Comps Fair Value

$27.07

Comparable-company valuation reference.

Analyst Price Target

$26.33

Analysts imply upside of 1.6%.

How to read these valuation models

Use the 7 available valuation references for Pediatrix Medical Group Inc (NYSE-MD) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Pediatrix Medical Group Inc (NYSE-MD)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.951 B

Current operating scale indicator.

Revenue Forecast

1.96 B

Forward revenue estimate.

EBITDA

263.7 M

Current operating profitability reference.

EBITDA Forecast

290.4 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Pediatrix Medical Group Inc (NYSE-MD) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Pediatrix Medical Group Inc (NYSE-MD)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.78

No elevated caution signal from this screen.

Altman Z-Score

4.4

Relatively strong balance-sheet zone.

FCF / Net Income

130.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Pediatrix Medical Group Inc (NYSE-MD). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Pediatrix Medical Group Inc (NYSE-MD)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

October 29, 2026

Days to Earnings

41

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Pediatrix Medical Group Inc (NYSE-MD), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Pediatrix Medical Group Inc (NYSE-MD) Stock Forecast & Technical Outlook

Review Pediatrix Medical Group Inc (NYSE-MD) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Pediatrix Medical Group Inc (NYSE-MD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Pediatrix Medical Group Inc (NYSE-MD) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Pediatrix Medical Group Inc (NYSE-MD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Pediatrix Medical Group Inc (NYSE-MD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Pediatrix Medical Group Inc (NYSE-MD) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Pediatrix Medical Group Inc (NYSE-MD)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Pediatrix Medical Group Inc (NYSE-MD) has a Hold consensus, with 1 buy, 6 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 6
Sell 0
FAQ Fast Investor Answers

Pediatrix Medical Group Inc (NYSE-MD) Stock FAQ

Data-supported answers about Pediatrix Medical Group Inc (NYSE-MD), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$32.08
Estimated upside 23.7%
Valuation Rating
Undervalued
Estimated upside of 23.7%
Analyst Target
$26.33
Implied upside 1.6%
Financial Health
Great
Current financial-health read

The current fair value estimate for Pediatrix Medical Group Inc (NYSE-MD) is $32.08. This implies an estimated upside of 23.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 23.7% versus the current market price.

The available analyst price target for Pediatrix Medical Group Inc (NYSE-MD) is $26.33. The analyst target implies estimated upside of 1.6%.

The current financial health read for Pediatrix Medical Group Inc (NYSE-MD) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Pediatrix Medical Group Inc (NYSE-MD) is October 29, 2026.

The latest available data indicates no current dividend yield for Pediatrix Medical Group Inc (NYSE-MD).

The current P/E ratio listed for Pediatrix Medical Group Inc (NYSE-MD) is 11.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Pediatrix Medical Group Inc is 2.057 B.

The current enterprise value listed for Pediatrix Medical Group Inc is 2.238 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Pediatrix Medical Group Inc is NYSE-MD, and the stock is listed on NYSE.

Pediatrix Medical Group Inc (NYSE-MD) is listed on NYSE.

The current debt-to-total-capital ratio listed for Pediatrix Medical Group Inc is 23.2%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Pediatrix Medical Group Inc is 98.2%. Free float helps investors understand how much of the share base is available for public trading.